What type of muscle weakness does dermatomyositis cause?
Symmetrical proximal muscle weakness.
What makes dermatomyositis distinct from polymyositis?
Characteristic skin lesions are present.
Is dermatomyositis idiopathic or associated with other diseases?
It may be idiopathic or associated with connective tissue disorders or underlying malignancy.
Which cancers are commonly associated with dermatomyositis?
Ovarian, breast, and lung cancers.
What percentage of dermatomyositis patients have an associated malignancy?
20–25% (higher in older adults).
What major clinical step must be performed after diagnosing dermatomyositis?
Screening for underlying malignancy.
What condition is considered a variant of dermatomyositis without skin features?
Polymyositis.
What type of rash on the back and shoulders is characteristic of dermatomyositis?
Photosensitive macular rash.
What is the classic periorbital rash seen in dermatomyositis?
Heliotrope rash.
What are Gottron’s papules?
Roughened red papules over the extensor surfaces of the fingers.
What are “mechanic’s hands” in dermatomyositis?
Extremely dry, scaly hands with linear cracks on the palmar and lateral aspects of the fingers.
What nail sign is associated with dermatomyositis?
Nail fold capillary dilatation.
What systemic symptom involving circulation may occur in dermatomyositis?
Raynaud’s phenomenon.
What respiratory complication can dermatomyositis cause?
Respiratory muscle weakness.
Which interstitial lung diseases may occur in dermatomyositis?
Fibrosing alveolitis or organising pneumonia.
What oesophageal and laryngeal symptoms can occur in dermatomyositis?
Dysphagia and dysphonia.
Are ANA antibodies common in dermatomyositis?
Yes — around 80% are ANA positive.
What proportion of dermatomyositis patients have anti-synthetase antibodies?
Around 30%.
Which anti-synthetase antibody targets histidine-tRNA ligase?
Anti-Jo-1.
Which autoantibody targets the signal recognition particle (SRP)?
Anti-SRP antibody.
Which antibody is classically associated with dermatomyositis and good response to therapy?
Anti-Mi-2 antibody.